What is Cloacina?
Cloacina operates as a family-owned enterprise, leveraging four generations of expertise to deliver high-performance wastewater treatment systems. The company specializes in the fabrication of Membrane Bioreactors, Aerated Sludge Handling Systems, and Primary Treatment Systems. By focusing on durable, stainless steel construction, Cloacina provides essential infrastructure to sectors ranging from commercial wineries and food and beverage production to municipal water management. Their unique value proposition lies in the integration of licensed professional oversight with robust, modular equipment design, ensuring compliance and efficiency in complex environmental regulatory landscapes.
How much funding has Cloacina raised?
Cloacina has raised a total of $762K across 2 funding rounds:
Debt
$350K
Debt
$412K
Debt (2020): $350K with participation from PPP
Debt (2021): $412K led by PPP
Key Investors in Cloacina
PPP
Public-Private Partnership
What's next for Cloacina?
The infusion of capital positions Cloacina to accelerate its growth trajectory within the industrial water treatment sector. As the demand for sustainable and reliable wastewater management intensifies, the company is well-positioned to expand its footprint in the engineering and development markets. Future strategic initiatives will likely focus on enhancing manufacturing throughput and deepening the integration of advanced treatment technologies. By maintaining its focus on high-quality, stainless steel infrastructure, Cloacina is poised to capture additional market share, providing critical support to municipalities and private enterprises seeking to modernize their environmental compliance frameworks.
See full Cloacina company page
